Key facts
- It has raised $8.1M across 3 recorded rounds; the latest was Early Stage VC ($7.0M) in Feb 2025.
- Notable investors include Exit 156 Capital, Michael Nathan, Vail Investor Group.
- Vail Scientific has filed 3 Form Ds with the SEC since 2021, most recently Mar 2025 ($7.0M sold to 13 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 3 rounds
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Vail Scientific
Funding rounds
3 roundsAbout Vail Scientific
Developer of medical device technology products intended to provide rapid diagnosis of diverse diseases. The company's medical device measures two components in exhaled breath that include nitric oxide and carbon dioxide, and its proprietary algorithm provides a predictive probability of sepsis risk for a given patient, enabling healthcare providers to execute reliable medical identification and reduce unnecessary antibiotic treatments for patients.
- Sector
- Healthcare
- HQ
- Bloomington, MN, United States
- Founded
- 2015
- Employees
- 7
- Website
- vailscientific.com/
- Ownership
- Privately Held (backing)
Vail Scientific doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Vail Scientific shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Vail Scientific in its N-PORT filings yet. We sweep new filings monthly.